Kazuyuki Shimizu
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison study.
Journal: Haematologica
Published: January 22, 2025
Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan.
Journal: EJHaem
Published: May 21, 2022
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval.
Journal: Journal of bone oncology
Published: November 08, 2021
Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma.
Journal: Journal of cancer research and clinical oncology
Published: April 06, 2021
Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis.
Journal: Advances in therapy
Published: April 29, 2020
Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).
Journal: International journal of hematology
Published: May 24, 2019
Report of phase I and II trials of melphalan, prednisolone, and thalidomide triplet combination therapy versus melphalan and prednisolone doublet combination therapy in Japanese patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplantation.
Journal: International journal of hematology
Published: January 15, 2019
Patients assigned to VGPR, PR, and SD in the IMWG response category are composed of heterogeneous population when assessed by the heavy/light chain assay.
Journal: Hematological oncology
Published: December 31, 2018
Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).
Journal: International journal of hematology
Published: October 16, 2018
Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma.
Journal: Annals of hematology
Published: August 31, 2018
Last Updated: 09/26/2026